Single Ascending Doses of ZP4207 Administered in HV and in T1D to Evaluate Safety, Tolerability PKs and PDs of ZP4207 Compared to a Comparator
Clinical trial NCT02367053 · COMPLETED
Trial details
- NCT number
- NCT02367053
- Sponsor
- Zealand Pharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2015-04-01
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.